The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]


Variant: NM_175914.5(HNF4A):c.335G>A (p.Arg112Gln)

CA409105430

427034 (ClinVar)

Gene: HNF4A
Condition: monogenic diabetes
Inheritance Mode: Autosomal dominant inheritance
UUID: 9374a449-3776-451d-b6e1-4eb50bcbc616

HGVS expressions

NM_175914.5:c.335G>A
NM_175914.5(HNF4A):c.335G>A (p.Arg112Gln)
NC_000020.11:g.44413709G>A
CM000682.2:g.44413709G>A
NC_000020.10:g.43042349G>A
CM000682.1:g.43042349G>A
NC_000020.9:g.42475763G>A
NG_009818.1:g.62909G>A
ENST00000316099.10:c.401G>A
ENST00000619550.5:c.375G>A
ENST00000683148.1:n.377G>A
ENST00000683657.1:n.1525G>A
ENST00000316099.9:c.401G>A
ENST00000316099.8:c.401G>A
ENST00000316673.8:c.335G>A
ENST00000372920.1:c.*168G>A
ENST00000415691.2:c.401G>A
ENST00000443598.6:c.401G>A
ENST00000457232.5:c.335G>A
ENST00000609795.5:c.335G>A
ENST00000619550.4:c.326G>A
NM_000457.4:c.401G>A
NM_001030003.2:c.335G>A
NM_001030004.2:c.335G>A
NM_001258355.1:c.380G>A
NM_001287182.1:c.326G>A
NM_001287183.1:c.326G>A
NM_001287184.1:c.326G>A
NM_175914.4:c.335G>A
NM_178849.2:c.401G>A
NM_178850.2:c.401G>A
NM_001030003.3:c.335G>A
NM_001030004.3:c.335G>A
NM_001258355.2:c.380G>A
NM_001287182.2:c.326G>A
NM_001287184.2:c.326G>A
NM_178849.3:c.401G>A
NM_178850.3:c.401G>A
NM_000457.5:c.401G>A
NM_000457.6:c.401G>A
NM_001287183.2:c.326G>A

Pathogenic

Met criteria codes 7
PM2_Supporting PP4_Moderate PP1_Strong PM5_Supporting PP3 PM1 PS4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for HNF4A Version 1.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.335G>A variant in the hepatic nuclear factor 4-alpha gene, HNF4A, causes an amino acid change of arginine to glutamine at codon 112 (p.(Arg112Gln)) of NM_175914.5. This variant resides in an amino acid within the HNF4A DNA binding domain that directly binds DNA, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.959, which is greater than the MDEP VCEP threshold of 0.70 (PP3). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). This variant was identified in at least 17 unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes (PS4; PMIDs: 36257325, 25306193, 26552609, 18356407, internal lab contributors). At least one of these individuals had a clinical history highly specific for HNF4A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF1A, and sulfonylurea-responsive) (PP4_Moderate; internal lab contributors). This variant segregated with diabetes, with 12 informative meioses in 11 families (PP1_Strong; PMID: 18356407, internal lab contributors). Another missense variant, c.334C>T p.Arg112Trp, has been classified as pathogenic by the ClinGen MDEP but has a greater Grantham distance than p.Arg112Gln (PM5_Supporting). In summary, c.335A>G meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 1.1.0, approved 8/11/2023): PS4, PP1_Strong, PM1, PP4_Moderate, PP3, PM2_Supporting, PM5_Supporting.
Met criteria codes
PM2_Supporting
This variant is absent from gnomAD v2.1.1 (PM2_Supporting).
PP4_Moderate
This variant was identified in an individual with a clinical history highly specific for HNF4A-MODY (MODY probability calculator result >50%, negative genetic testing for HNF1A, and sulfonylrea-responsive) (PP4_Moderate; internal lab contributors).
PP1_Strong
This variant segregated with diabetes, with 12 informative meioses in 11 families (PP1_Strong; PMID: 18356407, internal lab contributors).
PM5_Supporting
Another missense variant, c.334C>T p.Arg112Trp, has been classified as pathogenic by the ClinGen MDEP but has a greater Grantham distance than p.Arg112Gln (PM5_Supporting).
PP3
This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.959, which is greater than the MDEP VCEP threshold of 0.70 (PP3).
PM1
This variant resides in an amino acid within the HNF4A DNA binding domain that directly binds DNA, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1).
PS4
This variant was identified in at least 17 unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes (PS4; PMIDs: 36257325, 25306193, 26552609, 18356407, internal lab contributors).
Approved on: 2023-09-29
Published on: 2023-09-29
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.